RxDoctor Payments Data

Scott Kaszuba, MD

Otolaryngology · Naperville, ILNPI 1518994508

Payments from drug & device makers

$1,767in general payments, 2019–2025

Across 82 payments — averaging $21.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$220
  • GSK$208
  • IBSA Pharma Inc.$189
  • AbbVie$180
  • Amneal Pharmaceuticals LLC$177
  • Stryker$156
  • plus $637 from 16 others

What the payments were for

  • Food & beverage$1,767100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,767 in reported general payments places this provider in the 60th percentile of 390 otolaryngology providers in Illinois.

See all otolaryngology providers in Illinois

Medicare billing

Part B allowed, 2024
$190,453
Medicare patients
566
Services billed
1,741

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide243$10,521
Azelastine Hcl164$5,543
Fluticasone Propionate197$3,848
Montelukast Sodium215$2,331
Omeprazole84$1,102
Clarithromycin27$646
Levothyroxine Sodium62$644
Ofloxacin20$624
Famotidine53$595
Amitriptyline Hcl40$567
Levocetirizine Dihydrochloride32$520
Methylprednisolone68$439
Fluocinolone Acetonide Oil18$400
Gabapentin29$372
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen36$304

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Amneal Pharmaceuticals LLCLevothyroxine Sodium$177$64462 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 390 otolaryngology providers in Illinois.

Other otolaryngology in Naperville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →